The Importance of Visceral Adipose Tissue Detected by Imaging Methods to Assess Nonalcoholic Fatty Liver Disease Properly

Fatih Ozcelik, Namik Ozmen

Abstract


Dear Editor, We read the article entitled “The Effect of Symbiotic Supplementation on Liver Enzymes, C‑reactive protein (CRP), and ultrasound findings in patients with nonalcoholic fatty liver disease (NAFLD): A Clinical Trial” with great interest.[1] In this study, authors reported that symbiotic supplementation improved the grade of hepatosteatosis in NAFLD patients without any change in alanine aminotransferase, aspartate aminotransferase, and CRP levels. With this aspect, the current study offers a new perspective on the management of NAFLD. However, there is a lack of information about the association between amount of visceral adipose tissue (VAT) which is an important factor for fat accumulation in liver, presence of diabetes, metabolic syndrome (MetS), hyperlipidemia, and NAFLD. Therefore, we would like to make some important contributions in this regard.

Keywords


C‑reactive protein; nonalcoholic Fatty Liver Disease; visceral adipose tissue

Full Text:

PDF

References


Asgharian A, Askari G, Esmailzade A, Feizi A, Mohammadi V.

The effect of symbiotic supplementation on liver enzymes,

C‑reactive protein and ultrasound findings in patients with

non‑alcoholic fatty liver disease: A Clinical trial. Int J Prev Med

;7:59.

Lomonaco R, Ortiz‑Lopez C, Orsak B, Webb A, Hardies J,

Darland C, et al. Effect of adipose tissue insulin resistance on

metabolic parameters and liver histology in obese patients with

nonalcoholic fatty liver disease. Hepatology 2012;55:1389‑97.

Pihlajamäki J, Boes T, Kim EY, Dearie F, Kim BW, Schroeder J,

et al. Thyroid hormone‑related regulation of gene expression in

human fatty liver. J Clin Endocrinol Metab 2009;94:3521‑9.

Ozcelik F, Yuksel C, Arslan E, Genc S, Omer B, Serdar MA,

et al. Relationship between visceral adipose tissue and

adiponectin, inflammatory markers and thyroid hormones in

obese males with hepatosteatosis and insulin resistance. Arch Med Res 2013;44:273‑80.

Wajchenberg BL. Subcutaneous and visceral adipose tissue:

Their relation to the metabolic syndrome. Endocr Rev

;21:697‑738.